Rapid COVID-19 Antigen Self-Test developed by Orient Gene Biotech has obtained Coronavirus Test Device Approval (CTDA) from the UK for a period of 5 years. After obtaining certification, the Rapid COVID-19 Antigen Self-Test products are available for sale within the UK.
The Rapid COVID-19 Antigen Self-Test developed by Orient Gene Biotech uses nasal swab samples to detect whether there is infection with COVID-19. It is used for the detection of both symptomatic and asymptomatic individuals. The Rapid COVID-19 Antigen Self-Test has the following characteristics:
High sensitivity and specificity
Easy to use
Easy to interpret results in 15 minutes
Available for use at home
Early detection and treatment
Available in variable pack sizes
The certification of Rapid COVID-19 Antigen Self-Test signifies that the use of the 2019-nCoV antigen detection reagent developed by Orient Gene Biotech has been fully recognized, and it has been authorized to evolve from emergency-use to long-term certification, aiding in the UK’s containment efforts for the COVID-19 virus.
At present, with the reoccurrence of COVID-19, Orient Gene Biotech will continue to pool global scientific and technological strength to provide full support for the global fight against COVID-19.